Over the past 15 years, John Albis has built his career within Yale’s financial enterprise, progressing from a research accountant in Pediatrics to director of finance in the Integrated Business Office (IBO), supporting Surgery, Orthopedic Surgery, and Anesthesiology. Along the way, he has helped guide the organization through major transitions, including systems changes, new compensation models, the evolution of funds flow, and the phased development of the IBO itself. As he celebrates this milestone, John reflects on the changes that have shaped his career, the teams that have inspired him, and the work that continues to motivate him.
Q+A
John Albis: 15 Years of Leadership, Growth, and Financial Stewardship at Yale
How has your role evolved over the past 15 years at Yale, and what have been some of the most significant changes in the work?
The most significant evolution in my role has been the shift from primarily transactional and operational finance work to a much more strategic partnership with departmental leadership. Over time, the work has become increasingly focused on long-range planning, complex analysis, and ensuring financial sustainability in support of each department’s missions.
One of the biggest changes was the transition to funds flow, which fundamentally changed how we approach financial management. It created opportunities to engage more deeply in strategic analyses with departmental leaders, helping balance sustainability with mission priorities and market competitiveness.
What aspect of your work do you find most rewarding or meaningful?
Interestingly, the most rewarding moments often come during the most demanding times—year-end close, budget season, or periods of staffing shortages. What stands out most is watching our team come together, step up for one another, and collaborate under pressure to meet challenging deadlines. Seeing that level of commitment and teamwork has always been one of the most meaningful parts of my role.
Looking back, is there a project, initiative, or accomplishment that stands out as a point of pride?
Rather than a single project or moment, what gives me the greatest sense of pride is watching the professional growth of our team members over time. There is something especially rewarding about seeing someone develop new skills, take on greater responsibility, and ultimately earn a promotion—ideally within the IBO. Supporting that growth and helping create pathways for advancement has been one of the most fulfilling parts of my career.
What has been the most complex or challenging part of your role, and how have you approached it?
Without question, the most complex aspect has been change management. Over the last 15 years, both the business office and Yale School of Medicine have undergone significant transformations that have continually reshaped the way we work—from Oracle to Workday, the implementation of funds flow, new compensation plans, remote work transitions, and multiple phases of IBO development.
My approach has been to stay open-minded, even when change is difficult. I try to focus on understanding the purpose and benefits behind each shift, then help the team learn, adapt, and move forward together. It has not always been easy, but that mindset has been essential.
Who has had the greatest influence on your professional journey, and what lessons from them have stayed with you?
There have been several people who have had a profound influence on my professional journey. What they all share is a deep dedication to their work, a genuine investment in helping their teams succeed, and the ability to lead with confidence and steadiness. Just as importantly, they model the value of maintaining a healthy work-life balance—something that has stayed with me throughout my career and continues to shape my own leadership style.
As you think about the future, what professional goals continue to inspire you over the next chapter of your career?
We are in the middle of a major transition as the IBO undergoes restructuring, and we navigate the departure of several key team members through retirements and promotions. My primary focus right now is helping lead the team successfully through this period—meeting expectations, maintaining continuity, and continuing to invest in the development of our current staff.
Looking ahead, I would also welcome opportunities to contribute more broadly to higher-level Yale School of Medicine initiatives, particularly where strategic finance and organizational development intersect. The people and the opportunity to keep growing have made Yale an incredibly rewarding place to build a career.